![]() |
市場調查報告書
商品編碼
2049755
藥品瓶蓋及瓶蓋市場報告:按產品、材料、最終用戶和地區分類(2026-2034 年)Pharmaceutical Caps and Closures Market Report by Product, Material, End User (Pharmaceutical and Biotechnology Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic and Research Institutes), and Region 2026-2034 |
||||||
2025年,全球藥品瓶蓋市場規模達43億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到80億美元,2026年至2034年的複合年成長率(CAGR)為6.93%。癌症、糖尿病、氣喘和心血管疾病等慢性病和急性病的日益普遍,對安全有效包裝需求的成長,以及兒童安全包裝解決方案的推出,是推動市場成長的主要因素。
藥用瓶蓋和封口是氣密性密封產品,可保護藥品免受灰塵、濕氣和惡劣天氣的影響。它們由多種金屬材料和聚合物製成,包括高密度聚丙烯 (HDPP) 和聚乙烯。透過保護產品免受環境和微生物劣化,它們有助於延長藥品的保存期限。此外,它們還能提升產品外觀,並方便運送過程中的操作。而且,透過避免微生物侵襲和污染的風險,它們有助於減少廢棄物並延長預包裝藥品的保存期限。因此,全球對藥用瓶蓋和封口的需求正在不斷成長。
久坐的生活方式、人口老化和不健康的飲食習慣正在推動各種急性和慢性疾病的流行,包括高血壓、糖尿病、氣喘、肥胖症、慢性阻塞性肺病(COPD)、肌肉骨骼疾病和牙科疾病。這是推動全球對藥品包裝解決方案(例如瓶蓋和封口)需求的主要因素之一。對安全有效包裝解決方案日益成長的需求也推動了藥品瓶蓋和封口市場的創新。此外,為防止兒童誤食,對兒童安全包裝解決方案的需求不斷成長,也是支撐市場成長的另一個主要因素。此外,個人消費能力的提高以及醫院、門診手術中心(ASC)和其他醫療機構的擴張也推動了全球對藥品的需求。產業投資者致力於利用先進製造技術生產高精度、高效率和輕巧的瓶蓋和封口,這也有助於創造良好的市場前景。此外,塑膠瓶蓋和封口因其經濟、耐用和耐腐蝕的特性,在製藥業備受關注。主要市場參與者正在開發各種形狀和尺寸的客製化產品,並具備卓越的耐化學腐蝕性,以滿足終端用戶的需求。他們也致力於開發永續的蓋子與封口裝置解決方案,採用可回收或可生物分解的材料,以減少對環境的影響和產品開發成本,預計這將促進市場成長。
The global pharmaceutical caps and closures market size reached USD 4.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.93% during 2026-2034. The growing prevalence of chronic and acute conditions, such as cancer, diabetes, asthma, and cardiovascular diseases, rising need for safe and effective packaging, and the introduction of child-proof packaging solution represent some of the key factors driving the market.
Pharmaceutical caps and closures are air-tight sealing products that protect pharmaceutical items from dust, moisture, and unfavorable climatic conditions. They are made up of different metallic materials and polymers, such as high-density polypropylene (HDPP) and polyethylene. They help keep the content fresh for an extended period by protecting products from environmental and microbiological spoilage. They also enhance product aesthetics and make handling convenient during transportation from one place to another. In addition, they assist in minimizing wastage and increasing the shelf-life of packed medicines by averting the chances of microbial attacks and contamination. As a result, the demand for pharmaceutical caps and closures is increasing across the globe.
Due to sedentary lifestyles, rising geriatric population, and unhealthy dietary patterns, there is an increase in the prevalence of various acute and chronic conditions, such as hypertension, diabetes, asthma, obesity, COPD, musculoskeletal disorders, and dental problems. This represents one of the key factors catalyzing the demand for pharmaceutical packaging solutions like caps and closures across the globe. The escalating demand for safe and effective packaging solutions is also encouraging innovations in the pharmaceutical caps and closures market. Along with this, the rising need for child-proof packaging solutions to prevent kids from accidental consumption is another major factor supporting the growth of the market. Furthermore, the demand for pharmaceutical products is increasing worldwide with the increasing expenditure capacity of individuals and the expansion of hospitals, ambulatory surgical centers (ASCs), and other healthcare centers. Moreover, rising focus of industry investors on utilizing advanced manufacturing techniques for producing lightweight caps and closures with high precision and efficiency is offering a favorable market outlook. Apart from this, caps and closures manufactured with plastic are gaining immense traction in the pharmaceutical industry as they are economical, durable, and resistant to corrosion. Furthermore, leading market players are developing customized products in different shapes and sizes with superior chemical resistance properties to meet end-user requirements. They are also focusing on the development of sustainable closure solutions made from recyclable or biodegradable materials to reduce the environmental impact and product development costs, which is anticipated to propel the market growth.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for pharmaceutical caps and closures on account of the highly advanced and robust healthcare infrastructure, presence of well-established pharmaceutical industry, increasing investment in the healthcare industry, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global pharmaceutical caps and closures market. Detailed profiles of all major companies have been provided. Some of the companies covered include Amcor PLC, Aptar Group Inc., Bericap GmbH and Co. KG, Berry Global Group Inc., Closure Systems International Inc., Comar LLC, MJS Packaging, Pano Cap Canada Ltd, Saudi Basic Industries Corporation (Saudi Arabian Oil Co.), Tecnocap S.p.A., United Caps Luxembourg S.A., etc. Kindly note that this only represents a partial list of companies and the complete list has been provided in the report.